ArticleClinical drug investigation2017

Effectiveness of Switch to Erythropoiesis-Stimulating Agent (ESA) Biosimilars versus Maintenance of ESA Originators in the Real-Life Setting: Matched-Control Study in Hemodialysis Patients.

Roberto Minutolo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.